dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with paclitaxel in 1 studies
| Studies (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Trials (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Recent Studies (post-2010) (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 219 | 84 | 3 | 31,874 | 5,729 | 15,395 |
| Protein | Taxonomy | dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination (IC50) | paclitaxel (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.034 | |
| Integrin alpha-V | Homo sapiens (human) | 0.034 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.598 | |
| Botulinum neurotoxin type A | Clostridium botulinum | 5.2 | |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | 4.9 | |
| Substance-K receptor | Homo sapiens (human) | 6.125 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | 4.9 | |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | 4.9 | |
| Delta-type opioid receptor | Homo sapiens (human) | 4.202 | |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | 4.9 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.0082 | |
| Beta-tubulin | Leishmania donovani | 1 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 7.9433 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 0.26 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, R; Huilgol, N; Preetha, A | 1 |
1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and paclitaxel
| Article | Year |
|---|---|
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms | 2007 |